Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome
出版年份 2023 全文链接
标题
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome
作者
关键词
-
出版物
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-03
DOI
10.1038/s41409-023-02134-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT
- (2022) Raynier Devillier et al. BONE MARROW TRANSPLANTATION
- An 8-year pragmatic observation evaluation of the benefits of allogeneic HCT in older and medically infirm AML patients
- (2022) Mohamed Lotfy Sorror et al. BLOOD
- Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies
- (2022) Xia Bi et al. BONE MARROW TRANSPLANTATION
- Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies
- (2022) Rémy Duléry et al. BONE MARROW TRANSPLANTATION
- Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome
- (2021) Ryotaro Nakamura et al. JOURNAL OF CLINICAL ONCOLOGY
- In-depth time-dependent analysis of the benefit of Allo-HSCT for elderly patients with CR1 AML: a FILO study
- (2021) Raynier Devillier et al. Blood Advances
- Allogeneic hematopoietic cell transplantation for older patients
- (2021) Richard J. Lin et al. Hematology-American Society of Hematology Education Program
- Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of care
- (2021) Vanessa E Kennedy et al. Lancet Haematology
- Integration of a Geriatric Assessment With Intervention in the Care of Older Adults With Hematologic Malignancies
- (2021) Sarah A. Wall et al. Frontiers in Oncology
- Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age
- (2020) Colin Flannelly et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation Cyclophosphamide
- (2020) Amy E. DeZern et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients
- (2019) Angela Granata et al. BONE MARROW TRANSPLANTATION
- Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study
- (2019) Celalettin Ustun et al. LEUKEMIA
- Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- (2019) Olle Ringdén et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation
- (2019) Philip H. Imus et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
- (2018) Monzr M. Al Malki et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
- (2018) Helene M. Schoemans et al. BONE MARROW TRANSPLANTATION
- Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells
- (2018) Raphael Cauchois et al. BRITISH JOURNAL OF HAEMATOLOGY
- International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
- (2016) Andrew C. Harris et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML
- (2016) F Legrand et al. BONE MARROW TRANSPLANTATION
- Low incidence of chronic GVHD after HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in older patients
- (2016) Raynier Devillier et al. BRITISH JOURNAL OF HAEMATOLOGY
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
- (2015) Madan H. Jagasia et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
- (2015) S. R. McCurdy et al. BLOOD
- T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes
- (2015) R Devillier et al. BONE MARROW TRANSPLANTATION
- Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502
- (2015) Steven M. Devine et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
- (2015) Yvette L. Kasamon et al. JOURNAL OF CLINICAL ONCOLOGY
- HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM
- (2015) M Robin et al. LEUKEMIA
- Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis
- (2015) Jurjen Versluis et al. Lancet Haematology
- Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients
- (2014) L. S. Muffly et al. HAEMATOLOGICA
- Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial
- (2014) D. Blaise et al. HAEMATOLOGICA
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
- (2008) Leo Luznik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search